Insider Shareholders with Direct Ownership of Optimize Rx Corp (OPRX)
This section provides a comprehensive overview of the insiders with direct ownership of Optimize Rx Corp (OPRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
OptimizeRx Corp Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
William J Febbo
CEO |
627,176 | 255,638 | 601,253 $2.95 Million | 25 |
Dec 12, 2024
Added 3.22%
|
|
Gus D Halas
Director |
19,029 | 0 | 80,926 $397,346 | 9 |
Jun 05, 2024
Added 11.06%
|
|
Stephen L Silvestro
Chief Commercial Officer |
230,581 | 149,829 | 80,848 $396,963 | 30 |
Dec 19, 2024
Reduced 3.09%
|
|
Miriam J Paramore
PRESIDENT AND CSO |
91,891 | 175,753 | 71,049 $348,850 | 16 |
Dec 02, 2021
Reduced 4.77%
|
|
James Paul Lang
Director |
38,315 | 0 | 68,044 $334,096 | 11 |
Jun 07, 2024
Added 16.34%
|
|
Ellen O'Connor Vos
Director |
32,815 | 0 | 62,774 $308,220 | 11 |
Jun 07, 2024
Added 17.47%
|
|
Gregory D Wasson
Director |
32,315 | 0 | 47,315 $232,316 | 10 |
Jun 07, 2024
Added 21.92%
|
|
Patrick D Spangler
Director |
32,315 | 6,252 | 45,467 $223,242 | 11 |
Jun 07, 2024
Added 22.61%
|
|
Edward Stelmakh
CFO/COO |
79,423 | 20,281 | 37,287 $183,079 | 14 |
Dec 19, 2024
Reduced 3.41%
|
|
Theresa Greco
Chief Commercial Officer |
18,519 | 1,693 | 35,345 $173,543 | 2 |
Nov 01, 2024
Reduced 4.57%
|
|
Douglas P Baker
CHIEF FINANCIAL OFFICER |
105,316 | 161,222 | 34,796 $170,848 | 35 |
Oct 05, 2021
Reduced 22.32%
|
|
Marion Odence Ford
General Counsel and CCO |
41,389 | 14,159 | 27,230 $133,699 | 24 |
Dec 20, 2024
Reduced 4.06%
|
|
Doug Besch
Chief Product Officer |
12,612 | 2,529 | 11,583 $56,872 | 7 |
Dec 19, 2024
Reduced 4.75%
|
|
Cathy Klema
Director |
6,643 | 0 | 6,643 $32,617 | 1 |
Jun 07, 2024
Added 50.0%
|
|
Todd Inman
Chief Technology Officer |
771 | 233 | 538 $2,641 | 2 |
Mar 01, 2023
Reduced 30.22%
|